Below, find the full data for April’s 10 biggest pharma ad spenders, as compiled by iSpot.TV. 1. Skyrizi Movement: Up three spots What is it? AbbVie’s immunology drug Est. national TV ad spend ...

Skyrizi sales jumped 70.5% to $3.43 billion, and Rinvoq sales climbed 57.2% to $1.72 billion, exceeding forecasts. Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a ...

The decline was offset by sales of its newer arthritis drugs Skyrizi, which soared by 71% to $3.43 billion, and Rinvoq, which logged a 57% gain to $1.72 billion. Sales of its cosmetic botox ...

AbbVie's IL-23 inhibitor Skyrizi trailed some of its rivals in its first indication psoriasis, but has leapfrogged into first place in Crohn's disease after getting approval for the new indication ...

The pharmaceutical company, whose products include immunology treatments Skyrizi and Humira, as well as anti-wrinkle drug Botox, is the latest to outline plans to bolster its U.S. presence as the ...

Relying on lightweight and light-coverage picks for her go-to everyday makeup look, one of Meghan's firm favourites is this Yves Saint Laurent Touche Éclat Illuminating Pen, which she uses to ...

PARIS - Jordan Bardella plans to be the French far-right National Rally's presidential candidate in 2027 if the party's leader Marine Le Pen remains barred from running, he told Le Parisien newspaper.

Plus, AbbVie’s top-selling drug, Skyrizi, is made in the U.S., the CEO added. Nevertheless, AbbVie is bracing for potential near-term headwinds if pharmaceutical tariffs touch down, said CFO Reents.

By Roger Cohen Reporting from Paris Since a Paris court barred her from standing for public office, Marine Le Pen has denounced a “witch hunt,” accused “the system” of deploying “a ...

The French presidential elections are due no later than April 2027, and Le Pen was a leading candidate. Le Pen has tried thrice to be president and failed, so this was probably her last chance.